INSIGHT: What Chemical Industry Deals Si...

Industry headlines are driving strategic shifts in the chemical sector, and Victoria Meyer gives her candid perspective on what these major moves really mean for industry leaders and decision makers. This episode puts a spotlight on recent deals and boardroom decisions involving Shell, Olin, Huntsman, Solstice Advanced Materials, and H.B. Fuller. 

From Shell’s planned chemical asset sale to the Olin-Huntsman merger of equals, Victoria unpacks key questions: Is this a broader trend or company-specific? How does M&A activity impact value chains, partner relationships, and competitive dynamics? What does it signal about the future shape of the chemical industry? 

Victoria discusses: 

• Shell’s $8B US chemical asset sale and why Exxon, LyondellBasell, and investors are circling. 
• H.B. Fuller’s board rejecting a proposal from activist investor Ancora and why value creation looks different from the inside versus the outside. 
• Why Solstice and Element Solutions called off a $14.5B merger, insight into what “better alone than together” means in practice. 
• The Olin and Huntsman “merger of equals” and what’s behind their conviction that the whole is greater than the sum of the parts. 
• Broader market trends: Portfolio reshaping, supply chain considerations in deal-making, and what leaders must do to position their companies for future advantage. 

Article Links: 

• Solstice, Element terminate $14.5 billion merger deal after shareholder feedback 
• H.B. Fuller Board Unanimously Rejects Unsolicited Proposal from Ancora 
• Shell draws Exxon interest in $8bn US chemical assets sale 
• OLIN and HUNTSMAN Shareholders Approve Transformative Merger of Equals